A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis (MS) in Finland between 2013 and 2022.
A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It also gave University of Michigan researchers a first ...
5h
StarsInsider on MSNEverything you need to know about multiple sclerosisThe world is full of nasty and deadly diseases, but some of the worst are the ones that turn your own body against you.
A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It also gave researchers a look at how primary ...
Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic ...
A multicenter study led by researchers from the State Key Laboratory of Ophthalmology in China has characterized a distinct ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results